Aarti Industries Ltd (AARTIIND) Q1 FY27 Earnings Call: Maintains Rs.1,800 Cr EBITDA Guidance, Fuel Additives Capacity Reaches 360 KTPA

Aarti Industries Ltd held its Q1 FY27 earnings call on July 30, 2026. Here's a quick read of what management said — performance, strategy, and the outlook ahead.

Revenue, Profit & Headline Metrics

• Revenue grew 41% YoY to Rs.2,627 Cr in Q1 FY 2026-2027; EBITDA rose 79% YoY to Rs.385 Cr; PAT surged 266% YoY to Rs.155 Cr, with all three lines benefiting from volume, pricing, and one-time gains.
• Exports contributed 59% of Q1 FY 2026-2027 revenue; management expects export volumes to rise further in Q2 FY 2026-2027 while flagging quarter-on-quarter revenue recognition volatility from supply shifts to longer-voyage US destinations under DAP Incoterms.
• Q1 FY 2026-2027 volumes declined 17% QoQ in energy, 7% QoQ in non-energy, and ~12% QoQ overall; management has stopped disclosing absolute volume numbers and will instead report energy/non-energy volume trends and utilization ranges by value chain.
• Underlying EBITDA of ~Rs.300-310 Cr — an analyst estimated that stripping out the ~Rs.47 Cr forex benefit and ~Rs.50-60 Cr inventory gains leaves a base ~20% below the ~Rs.350 Cr quarterly run-rate management had previously telegraphed as consistent with the Rs.1,800 Cr FY 2026-2027 EBITDA target.

Capacity Expansion, Joint Ventures & Capital Allocation

• CAPEX guided at Rs.700-800 Cr for FY 2026-2027, with Rs.180 Cr deployed in Q1; management expects CAPEX intensity to reduce from FY 2027-2028 onward as the Zone 4 build-out nears completion.
• Fuel additives capacity expanded from 290 KTPA to 360 KTPA (brownfield, completed); DCB capacity debottlenecking to 140 KTPA is underway.
• JV with Superform for amine derivatives on track for commissioning in Q2 FY 2026-2027; Aarti Circularity (plastic recycling) slated for commissioning in H2 FY 2026-2027.
• Steady-state JV revenue guidance maintained at Rs.300-400 Cr, with meaningful PAT contribution expected within 2-4 quarters (i.e., by mid-FY 2027-2028) but initial visibility from Q2 FY 2026-2027.
• Subsidiary planned in China to enhance sourcing and market presence; management sees future capex allocation driven by value addition, global cost competitiveness, scalability, and return on capital, with current focus on battery chemicals and defense applications.
• Aarti Industries achieved EcoVadis Platinum rating, score 87/100, placing the company in the top 1% globally for sustainability performance.

MMA Diversification, Geopolitical Diversion & Demand Cycle

• West Asia conflict reduced exports to the region from 15% to 2% of revenues in Q1 FY 2026-2027; management successfully diverted energy product flows to the US, Africa, Europe, and India, supported by market development and strong gasoline/naphtha cracks.
• Gasoline-naphtha cracks averaged $15-18/barrel globally, back to pre-war levels per management, underpinning robust fuel-additive demand; the MMA/fuel additives market was described as “pretty strong” as of Q1 FY 2026-2027.
• Management is expanding the fuel additives portfolio beyond MMA with 3-5 products in development; scale-up expected over the next 12 months (through FY 2026-2027 into FY 2027-2028).
• Brownfield capacity for the overall fuel additives block reached 360 KT (not MMA-specific); management aims to stabilize that capacity over the next 12 months and expects to reach high utilization levels in Q2 FY 2026-2027.
• Winter season (end-October to December) typically weakens MMA demand, though current traction is strong; management is evaluating mitigation strategies for volume placements during the lean season.

EBITDA Trajectory, Forex, Inventory & Underlying Earnings

• Q1 FY 2026-2027 EBITDA of Rs.385 Cr included ~Rs.47 Cr forex benefit and an estimated ~Rs.50-60 Cr of inventory gains; CFO Chemtan Gandhi explained forex gains arose from rupee volatility in the 92-97 range and recommended treating them as part of operating profit given their link to imported inventory.
• Management declined to provide a specific Q2 FY 2026-2027 EBITDA run-rate forecast, citing monthly price corrections of ±15-20% and that Q1 gains may not repeat but could be offset by volume growth.
• The reported ~16% EBITDA margin in Q1 FY 2026-2027 is not assured to be maintained; volume growth is expected for FY 2026-2027, but pricing, margins, and inventory costs depend on the West Asia geopolitical situation and the pace of raw-material price changes.
• Gross margin declined sequentially due to within-quarter factors (timing of raw-material purchases, product mix, forex, freight, lower volumes) and is not reflective of steady-state performance, per management.
• Management hedges inventory risk via fast domestic pass-through (inventory of 7-15 days) and forward booking for imported materials (inventory of 1-1.5 months), mitigating crude-linked raw-material volatility.

Commissioning Delays, Chemistry Blocks & Product Pipeline

• Zone 4 commissioning delayed by at least 6 months for 5 chemistry blocks due to labor shortages (LPG issue, elections, monsoon), not market conditions; 97% of equipment erected, 85% of piping complete; management expects commissioning within FY 2026-2027.
• Despite the delay, FY 2027-2028 (FY28) guidance remains intact; JVs (OAG and RSL), the NPP, multipurpose plant, and calcium chloride unit in Zone 4 are expected to commission on track.
• Multi-purpose plant first product expected in August 2026 (Q2 FY 2026-2027); management targets 5-10 products in FY 2026-2027, scaling to 25-30 products by end of FY 2027-2028.
• Product mix diversified across agro, pharma, coatings, and polymers, avoiding concentration in one end-market; management changed Zone 4 strategy ~1.5 years ago to make the chain capable of multiple chemistries beyond chlorotoluene.
• Competition already exists with 2-3 players in India and China; management expressed confidence in maintaining cost leadership and market leadership through differentiation, global supply chain optimization, and distribution strategy.

Guidance, Demand Recovery & Macro Risks

• FY 2026-2027 EBITDA guidance of Rs.1,800 Cr includes the Aurigene JV; the RT JV is not expected to contribute meaningfully before FY 2027-2028, and the reporting treatment for JV EBITDA is yet to be decided.
• Demand recovery for polymers and agrochemicals expected in Q2 FY 2026-2027; non-energy volume softness in Q1 was attributed to supply-chain issues and delayed purchasing in a high-price environment, not Middle East disruption.
• Global majors (ExxonMobil, South Korean companies) have retired 10-15 million tons of ethylene/naphtha capacity over the past 12 months; management cited this rationalization, along with slowing expansion in China, as a potential basis for fundamental restructuring of the chemical industry margin profile post FY28-29, calling it a “personal hypothesis” requiring 2-3 more years to materialize.
• For ethylated products (e.g., OEA, 26 NEA), most contracts have pass-through pricing for ethylene, securing the margin profile per CEO Suog Kotecha; however, the products are not produced in Japan, South Korea, or Thailand, so the cracker closures in those regions do not present a direct opportunity for Aarti Industries.
• Pricing, margins, and inventory costs remain contingent on the West Asia geopolitical situation; management expressed confidence in volume growth for FY 2026-2027 but remains cautious on margins due to macro uncertainty, with ~16% Q1 margin not assured to be maintained.